Chris Duncombe

Statistics

Publications

Citations

2.5K

H-Index

Active since

1996

Affiliations

National Centre for Clinical Research on Emerging Drugs(Current)

UNSW Sydney

HIV Netherlands Australia Thailand Research Collaboration

Chulalongkorn University

Imperial College London

Chris Duncombe is an author at National Centre for Clinical Research on Emerging Drugs specializing in antiretroviral therapy, pharmacology, and antiviral therapy.

ORCID

Publications per year

1996–2019

Publications

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

Dennis Falzon, E. Jaramillo, Holger J. Schünemann et al. · European Respiratory Journal · 2011 · 1.1K citations · Full text

Public Health, Pharmacotherapy, Antimicrobial Pharmacotherapy +15

WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems

Shanthi Pal, Chris Duncombe, Dennis Falzon et al. · Drug Safety · 2013 · 235 citations · Full text

Pharmacy, Pharmacology, Patient Safety +13

Reframing HIV care: putting people at the centre of antiretroviral delivery

Chris Duncombe, Scott Rosenblum, Nicholas S. Hellmann et al. · Tropical Medicine & International Health · 2015 · 219 citations · Full text

Nursing, Health Services Administration, Health Systems +17

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort

W. Phillip Law, Chris Duncombe, Apicha Mahanontharit et al. · AIDS · 2004 · 155 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001

W. Phillip Law, Gregory J. Dore, Chris Duncombe et al. · AIDS · 2003 · 115 citations

Medicine, Infectious Diseases, Pharmacology +16

1–5 of 23